Clinical Trials

NCT07572123 | NOT_YET_RECRUITING | PHASE2/PHASE3
374 participants

Evaluating the Addition of Maintenance Immunotherapy Compared to the Usual Treatment of Chemotherapy and Autologous Stem Cell Transplant Alone for High-risk Patients With Relapsed or Refractory Hodgkin Lymphoma

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-08
Start Date:
2026-12-04
Completion:
2029-03-31
Conditions
  • Recurrent Classic Hodgkin Lymphoma
  • Refractory Classic Hodgkin Lymphoma
Interventions
  • RADIATION
  • PROCEDURE
  • DRUG
  • BIOLOGICAL
No Results Yet
NCT07566312 | NOT_YET_RECRUITING | PHASE4
25 participants

Study of QL Analgesic Response and Extent

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-08
Start Date:
2027-01-31
Completion:
2027-04-30
Conditions
  • Acute Pain
  • Postoperative Pain
  • Regional Anesthesia Block
Interventions
  • COMBINATION_PRODUCT
No Results Yet
NCT07529808 | RECRUITING | PHASE1/PHASE2
164 participants

Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-08
Start Date:
2026-07-31
Completion:
2028-12-31
Conditions
  • Gastric Cancer
  • Gastric Adenocarcinoma
  • Gastric (Stomach) Cancer
  • Gastroesophageal Adenocarcinoma
  • Gastroesophageal Cancer (GC)
  • Gastroesophageal Junction (GEJ) Adenocarcinoma
  • Gastroesophageal Junction (GEJ) Cancer
  • Gastrointestinal Cancer Metastatic
  • Gastrointestinal Adenocarcinoma
  • Gastrointestinal Cancers
  • Colorectal (Colon or Rectal) Cancer
  • Pancreatic Cancer
  • CDH17-positive Advanced Solid Tumors
  • Advanced Gastric Cancer
Interventions
  • DRUG
No Results Yet
NCT07521930 | RECRUITING | NA
5 participants

Interfacing With NeuroTechnology to Expand Neural Throughput (INTENT)

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-08
Start Date:
2026-08-31
Completion:
2028-06-30
Conditions
  • Brain Stem Stroke
  • Spinal Cord Injuries (SCI)
  • Muscular Dystrophies
  • Tetraplegia/Tetraparesis
  • Amyotrophic Lateral Sclerosis (ALS)
  • Muscular Disorders, Atrophic
  • Muscular Atrophy, Progressive
  • Pontine Hemorrhage
  • Pontine Infarction
Interventions
  • DEVICE
No Results Yet
NCT07504588 | NOT_YET_RECRUITING | PHASE2
87 participants

Sacituzumab Govitecan With Bevacizumab Compared to Usual Chemotherapy (Carboplatin, Pegylated Liposomal Doxorubicin and Bevacizumab) for Treating Recurrent Platinum-Sensitive Ovarian Cancer After PARP Inhibitor Maintenance Therapy

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-08
Start Date:
2026-09-10
Completion:
2029-04-12
Conditions
  • Recurrent Platinum-Sensitive Fallopian Tube Endometrioid Adenocarcinoma
  • Recurrent Platinum-Sensitive Fallopian Tube High Grade Serous Adenocarcinoma
  • Recurrent Platinum-Sensitive Ovarian High Grade Endometrioid Adenocarcinoma
  • Recurrent Platinum-Sensitive Ovarian High Grade Serous Adenocarcinoma
  • Recurrent Platinum-Sensitive Primary Peritoneal Endometrioid Adenocarcinoma
  • Recurrent Platinum-Sensitive Primary Peritoneal High Grade Serous Adenocarcinoma
Interventions
  • BIOLOGICAL
  • PROCEDURE
  • DRUG
No Results Yet
NCT07460752 | RECRUITING | PHASE2
98 participants

Evaluation of Alternative Site Goserelin Acetate Injection for Ovarian Function Suppression (OFS) in Local and Locally Advanced Premenopausal Hormone Receptor Positive Breast Cancer Patients

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-08
Start Date:
2026-05-22
Completion:
2028-09-26
Conditions
  • Anatomic Stage I Breast Cancer AJCC v8
  • Anatomic Stage II Breast Cancer AJCC v8
  • Anatomic Stage III Breast Cancer AJCC v8
  • Locally Advanced Hormone Receptor-Positive Breast Carcinoma
Interventions
  • PROCEDURE
  • DRUG
  • OTHER
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page